Pages that link to "Q42457537"
Jump to navigation
Jump to search
The following pages link to Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration (Q42457537):
Displaying 37 items.
- The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2 (Q27011665) (← links)
- The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes (Q27025731) (← links)
- Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update (Q28076062) (← links)
- Clinicopathological correlations in corticobasal degeneration (Q28245070) (← links)
- Percutaneous disc decompression with nucleoplasty-volumetry of the nucleus pulposus using ultrahigh-field MRI (Q28728796) (← links)
- Magnetic resonance imaging in progressive supranuclear palsy (Q33779124) (← links)
- Spread deficits in initiation, speed and accuracy of horizontal and vertical automatic saccades in dementia with lewy bodies (Q34462718) (← links)
- Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS study (Q34527147) (← links)
- Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts (Q34554452) (← links)
- Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy. (Q35479731) (← links)
- Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease (Q35523746) (← links)
- Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome (Q35540064) (← links)
- Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases (Q36110771) (← links)
- Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy. (Q36354065) (← links)
- Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease (Q36633135) (← links)
- Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors (Q36772321) (← links)
- MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice (Q37082107) (← links)
- Voxel-based morphometry in autopsy proven PSP and CBD (Q37243463) (← links)
- Rates of cerebral atrophy differ in different degenerative pathologies (Q37363768) (← links)
- The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy (Q37536338) (← links)
- Cognitive dysfunction in corticobasal degeneration. (Q38372130) (← links)
- Progression of brain atrophy in PSP and CBS over 6 months and 1 year (Q38811506) (← links)
- Magnetic resonance imaging for the diagnosis of Parkinson's disease (Q39220904) (← links)
- Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. (Q39225747) (← links)
- Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? (Q39303669) (← links)
- Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging (Q44387893) (← links)
- Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy (Q45229787) (← links)
- Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction (Q46437425) (← links)
- Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. (Q46514864) (← links)
- Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations (Q48589895) (← links)
- Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy (Q48664233) (← links)
- New Imaging Markers for Movement Disorders. (Q52317290) (← links)
- MR imaging of brainstem atrophy in progressive supranuclear palsy (Q57306357) (← links)
- MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease (Q57911761) (← links)
- MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism (Q64905445) (← links)
- [Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors] (Q80769369) (← links)
- Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome (Q85020419) (← links)